Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$29K Hold
350
﹤0.01% 377
2022
Q1
$29K Sell
350
-100
-22% -$7.83K ﹤0.01% 410
2021
Q4
$34K Hold
450
﹤0.01% 396
2021
Q3
$34.1K Hold
450
﹤0.01% 663
2021
Q2
$34.8K Hold
450
﹤0.01% 686
2021
Q1
$31.6K Hold
450
﹤0.01% 655
2020
Q4
$31.9K Hold
450
﹤0.01% 611
2020
Q3
$25.8K Hold
450
﹤0.01% 592
2020
Q2
$27.4K Hold
450
﹤0.01% 564
2020
Q1
$24.7K Sell
450
-545
-55% -$36.5K ﹤0.01% 519
2019
Q4
$71.8K Hold
995
0.01% 392
2019
Q3
$65.8K Hold
995
0.01% 402
2019
Q2
$61.8K Hold
995
0.01% 415
2019
Q1
$53.8K Hold
995
0.01% 441
2018
Q4
$58.3K Hold
995
0.01% 407
2018
Q3
$65.7K Hold
995
0.01% 418
2018
Q2
$65.9K Hold
995
0.01% 418
2018
Q1
$66.4K Hold
995
0.01% 412
2017
Q4
$65.2K Hold
995
0.01% 421
2017
Q3
$64K Buy
+995
New +$64.2K 0.01% 437

Other funds holding DOX

RBC Europe's DOX Position: Q2 2022 in Review

RBC Europe held its Amdocs (DOX) position steady in Q2 2022 at 350 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

RBC Europe first reported a position in DOX in Q3 2017 and has held it in 20 quarters since. The position peaked at $71.8K in Q4 2019. 451 funds tracked by Wall St. Rank hold DOX as of Q2 2022.

  • RBC Europe held 350 shares of Amdocs worth $29K as of Q2 2022.
  • RBC Europe left its Amdocs share count unchanged in Q2 2022.
  • Amdocs made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #377 holding.
  • RBC Europe first reported a position in Amdocs in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Amdocs position peaked at $71.8K in Q4 2019.
  • 451 funds tracked by Wall St. Rank held Amdocs as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.